Use of Test Results

Whenever the EPA receives test data it pubhshes a notice in the Federal Register and makes the nonconfidential portions of the data available to the public.  

If the test data indicates that there may be a reasonable basis to conclude that the chemical presents a significant risk of serious or widespread harm to human beings from cancer, gene mutation or birth defects, the EPA has one hundred eighty days to initiate an action under 5,6, or 7 of TSCA to prevent or reduce the risk, or publish a statement in the Federal Register explaining its conclusion that the risk is not unreasonable. The Administrator may extend the time by no more than ninety days. The standards embodied in this section are consistent with the objectives of the drafters—before the EPA must take 

Once a test rule issues, any exporter of the chemical subject to that rule must file a notice of export under 12(b). Generally, the requirement to file notices of export terminates when the test rule sunsets. However, the requirement to file notices of export for dioxins and dibenzofurans terminates only if all the required data has been submitted and there are no positive test results.  

---

Forecasting of time series behavior using lead time data (data obtained during current experiment) for prediction of the material response to the similar actions and loads in future or of testing results for twin material specimens during lead time . 

Calibration. Cahbration of lab instmments is important to the accuracy of test results. CaUbration, the use of an accepted standard to adjust an instmment or measurement standard so as to improve the accuracy of the instmment or measurement, is an essential requirement of both the U.S. Food and Dmg Administration (FDA) Good Manufacturing Practice (GMP) (24) and the ISO 9000 standards (25). 

The reproducibility of test results between labs using the neutral salt spray tests has not been consistent, but the repeatability, within one lab, is better, and the test has value in comparing variations in coating systems. Correlation of hours of exposure in the salt spray test to actual performance of the plated part in service, even in marine atmospheres, is not consistent and usually avoided. A classic example is that cadmium deposits outlast zinc deposits on steel in salt spray tests and clean marine atmospheres, yet zinc outlasts cadmium when exposed to real, industrial atmospheres, because of the presence of sulfur-bearing corrodents in industrial environments. An important variable in salt spray testing is the position of the surface to be tested. Whereas the surface of test panels is specified to be 15—30° from the vertical (40), when salt spray testing chromated zinc-plated specimens, this range has appeared excessive (41). 

Table 9.7 summarizes the comparison of SEC column performance with regard to particle size of the packing material. The author tried to create this table using the test results of different manufacturers of styrene-divinyl-benzene columns. 

Using the test results, draw conclusions as to the validity of the theory... 

Let it be known that one can say the tests are essential and all provide useful functions. However like design, material and process variables that exist, there are also testing variables. In order to apply them to a design, the designer should understand their meanings and purpose for existing. The result will be the proper use of tests. 

The scheme of commercial methane synthesis includes a multistage reaction system and recycle of product gas. Adiabatic reactors connected with waste heat boilers are used to remove the heat in the form of high pressure steam. In designing the pilot plants, major emphasis was placed on the design of the catalytic reactor system. Thermodynamic parameters (composition of feed gas, temperature, temperature rise, pressure, etc.) as well as hydrodynamic parameters (bed depth, linear velocity, catalyst pellet size, etc.) are identical to those in a commercial methana-tion plant. This permits direct upscaling of test results to commercial size reactors because radial gradients are not present in an adiabatic shift reactor. 

Alkaline phosphatase assays based on 3-glycerophosphate now appears to be obsolete, and methods buffered by either glycine or barbital are also obsolete as these buffers inhibit ALP or are poor buffers. Serum alkaline phosphatase is known to be composed of several isoenzymes which presumably arise from bone, liver, intestine, and placenta. The placental alkaline phosphatase is known to be much more resistant to heat denaturation than the other isoenzymes, and this resistance provides a simple test for it (5). The other enzymes can be separated through the differential inhibition by phenylalanine, by electrophoresis and by specific antibodies. However, the clinical usefulness of the results obtained is in doubt (23). 

The file Is used routinely In the laboratory at the National Institutes of Health In an attempt to explain abnormal test results The resident physicians affiliated with the Clinical Chemistry Service discuss the results with the patient-care physicians and determine If the results were due to the patient s clinical state or to a drug effect This close monitoring of test results has led to recognition of deficiencies In what Is believed are specific enzymatic procedures for the measurement of glucose and uric acid Likewise, the gualac procedure for occult blood In feces was found to yield false negative results under certain circumstances This has prompted the development of a more specific procedure (Jaffe et al unpublished) ... 

Three tests of this characteristic were discussed in the previous chapters the FDA/ICH recommendation of linear regression with a report of various regression statistics, visual inspection of a plot of test results versus the actual concentrations, and use of the Durbin-Watson Statistic. Since we previously analyzed these tests we will not further discuss them here, but will summarize them in Table 65-1, along with other tests for nonlinearity that we explain and discuss in this chapter. 

Even if quantitative results are more often expected for wastewater quality measurement, qualitative information is of great interest, as is the case for other applications of the analytical sciences (in the health sector, the use of test kits and biodiagnostic systems leads to quick and useful information, often far from a classical analytical result). In fact, quantitative analysis gives the concentration not only of one substance, but also of a group of comparable substances (surfactants, PAH,...), and even the value of a specific (TOC, TKN,...) or aggregate (BOD, COD, toxicity,...) parameter. In this context, total indices are often proposed as parameters complementary to classical analytical results [1]. 

The selection and use of testing equipment and procedures, and particularly the interpretation of the results, requires competent people. Some major companies have their own testing facilities, but there are a number of testing houses and consultancies available that you could use. 

Five of the seven respondents who use a matrix also use chemical testing results as a data source. A similar number review the matrix during qualitative hazard evaluation studies (i.e., hazard and operability [HAZOP] studies, what-if, checklist, etc.). 

If reference materials are not available, the challenge study lives np to its name. Specificity may still be demonstrated by a comparison of test results containing the impurities of interest to a second, well-characterized procedure (e.g., USP method). If a secondary method is unavailable, peak purity evaluation may be used to further demonstrate specificity of the method. 

When the laboratory uses different methodologies or instruments, or performs testing at multiple testing sites, a system is to be in place that evaluates and verifies the comparability between these test results. For example, correlation studies must ensure that manual and automated methods of immunostaining within a laboratory are in agreement. This must be documented biannually. In addition, any reference laboratories utilized must be CLIA-88-certified, and the lab director must monitor the quality of test results received from these outside sources. A mechanism must be in place to evaluate immunohistochemical results that are inconsistent with clinicopathologic studies. This evaluation should be performed and recorded by a laboratory physician. 

Certain substances may need special consideration, such as highly electrophilic substances, which give positive results in vitro, particularly in the absence of metabolic activation. Although these substances may react with proteins and water in vivo and thus be rendered inactive toward many tissues, they may be able to express their mutagenic potential at the first site of contact with the body. Consequently, the use of test methods that can be applied to the respiratory tract, upper gastrointestinal tract, and skin may be appropriate. 

Reliability is a more customer-friendly term for uncertainty Users of test results, including legislators and competent authorities do not always understand how uncertainty can be used to help them meet their needs. 

---